233 related articles for article (PubMed ID: 30285435)
1. Structure-Based Evolution of Low Nanomolar O-GlcNAc Transferase Inhibitors.
Martin SES; Tan ZW; Itkonen HM; Duveau DY; Paulo JA; Janetzko J; Boutz PL; Törk L; Moss FA; Thomas CJ; Gygi SP; Lazarus MB; Walker S
J Am Chem Soc; 2018 Oct; 140(42):13542-13545. PubMed ID: 30285435
[TBL] [Abstract][Full Text] [Related]
2. O-GlcNAc Transferase: Structural Characteristics, Catalytic Mechanism and Small-Molecule Inhibitors.
Ju Kim E
Chembiochem; 2020 Nov; 21(21):3026-3035. PubMed ID: 32406185
[TBL] [Abstract][Full Text] [Related]
3. A small molecule that inhibits OGT activity in cells.
Ortiz-Meoz RF; Jiang J; Lazarus MB; Orman M; Janetzko J; Fan C; Duveau DY; Tan ZW; Thomas CJ; Walker S
ACS Chem Biol; 2015 Jun; 10(6):1392-7. PubMed ID: 25751766
[TBL] [Abstract][Full Text] [Related]
4. Targeted covalent inhibition of O-GlcNAc transferase in cells.
Worth M; Hu CW; Li H; Fan D; Estevez A; Zhu D; Wang A; Jiang J
Chem Commun (Camb); 2019 Oct; 55(88):13291-13294. PubMed ID: 31626249
[TBL] [Abstract][Full Text] [Related]
5. O-GlcNAc transferase inhibitors: current tools and future challenges.
Trapannone R; Rafie K; van Aalten DM
Biochem Soc Trans; 2016 Feb; 44(1):88-93. PubMed ID: 26862193
[TBL] [Abstract][Full Text] [Related]
6. Thio-Linked UDP-Peptide Conjugates as O-GlcNAc Transferase Inhibitors.
Rafie K; Gorelik A; Trapannone R; Borodkin VS; van Aalten DMF
Bioconjug Chem; 2018 Jun; 29(6):1834-1840. PubMed ID: 29723473
[TBL] [Abstract][Full Text] [Related]
7. Versatile O-GlcNAc transferase assay for high-throughput identification of enzyme variants, substrates, and inhibitors.
Kim EJ; Abramowitz LK; Bond MR; Love DC; Kang DW; Leucke HF; Kang DW; Ahn JS; Hanover JA
Bioconjug Chem; 2014 Jun; 25(6):1025-30. PubMed ID: 24866374
[TBL] [Abstract][Full Text] [Related]
8. O-GlcNAcase: Emerging Mechanism, Substrate Recognition and Small-Molecule Inhibitors.
Elbatrawy AA; Kim EJ; Nam G
ChemMedChem; 2020 Jul; 15(14):1244-1257. PubMed ID: 32496638
[TBL] [Abstract][Full Text] [Related]
9. Substrate and product analogues as human O-GlcNAc transferase inhibitors.
Dorfmueller HC; Borodkin VS; Blair DE; Pathak S; Navratilova I; van Aalten DM
Amino Acids; 2011 Mar; 40(3):781-92. PubMed ID: 20640461
[TBL] [Abstract][Full Text] [Related]
10. Intracellular Hydrolysis of Small-Molecule
Loi EM; Weiss M; Pajk S; Gobec M; Tomašič T; Pieters RJ; Anderluh M
Molecules; 2020 Jul; 25(15):. PubMed ID: 32722493
[No Abstract] [Full Text] [Related]
11. Inhibition of O-Linked N-Acetylglucosamine Transferase Reduces Replication of Herpes Simplex Virus and Human Cytomegalovirus.
Angelova M; Ortiz-Meoz RF; Walker S; Knipe DM
J Virol; 2015 Aug; 89(16):8474-83. PubMed ID: 26041297
[TBL] [Abstract][Full Text] [Related]
12. Label-free electrochemical biosensing of small-molecule inhibition on O-GlcNAc glycosylation.
Yang Y; Gu Y; Wan B; Ren X; Guo LH
Biosens Bioelectron; 2017 Sep; 95():94-99. PubMed ID: 28427012
[TBL] [Abstract][Full Text] [Related]
13. Discovery of O-GlcNAc transferase inhibitors.
Gross BJ; Kraybill BC; Walker S
J Am Chem Soc; 2005 Oct; 127(42):14588-9. PubMed ID: 16231908
[TBL] [Abstract][Full Text] [Related]
14. Chemical tools to explore nutrient-driven O-GlcNAc cycling.
Kim EJ; Bond MR; Love DC; Hanover JA
Crit Rev Biochem Mol Biol; 2014; 49(4):327-42. PubMed ID: 25039763
[TBL] [Abstract][Full Text] [Related]
15. Discovery of two non-UDP-mimic inhibitors of O-GlcNAc transferase by screening a DNA-encoded library.
Balsollier C; Bijkerk S; de Smit A; van Eekelen K; Bozovičar K; Husstege D; Tomašič T; Anderluh M; Pieters RJ
Bioorg Chem; 2024 Jun; 147():107321. PubMed ID: 38604018
[TBL] [Abstract][Full Text] [Related]
16. Bisubstrate Ether-Linked Uridine-Peptide Conjugates as O-GlcNAc Transferase Inhibitors.
Makwana V; Ryan P; Malde AK; Anoopkumar-Dukie S; Rudrawar S
ChemMedChem; 2021 Feb; 16(3):477-483. PubMed ID: 32991074
[TBL] [Abstract][Full Text] [Related]
17. Bisubstrate UDP-peptide conjugates as human O-GlcNAc transferase inhibitors.
Borodkin VS; Schimpl M; Gundogdu M; Rafie K; Dorfmueller HC; Robinson DA; van Aalten DM
Biochem J; 2014 Feb; 457(3):497-502. PubMed ID: 24256146
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Cell-Permeable O-GlcNAc Transferase Inhibitors via Tethering in Situ Click Chemistry.
Wang Y; Zhu J; Zhang L
J Med Chem; 2017 Jan; 60(1):263-272. PubMed ID: 28032764
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Inhibitors of O-GlcNAc Transferase That Act In Vivo Implicate Decreased O-GlcNAc Levels in Leptin-Mediated Nutrient Sensing.
Liu TW; Zandberg WF; Gloster TM; Deng L; Murray KD; Shan X; Vocadlo DJ
Angew Chem Int Ed Engl; 2018 Jun; 57(26):7644-7648. PubMed ID: 29756380
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a Low Toxicity O-GlcNAc Transferase (OGT) Inhibitor by Structure-based Virtual Screening of Natural Products.
Liu Y; Ren Y; Cao Y; Huang H; Wu Q; Li W; Wu S; Zhang J
Sci Rep; 2017 Sep; 7(1):12334. PubMed ID: 28951553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
